help button home button Am J Pathol Angiogenesis Meeting
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Argani, P.
Right arrow Articles by Ladanyi, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Argani, P.
Right arrow Articles by Ladanyi, M.
(American Journal of Pathology. 2001;159:179-192.)
© 2001 American Society for Investigative Pathology


Regular Articles

Primary Renal Neoplasms with the ASPL-TFE3 Gene Fusion of Alveolar Soft Part Sarcoma

A Distinctive Tumor Entity Previously Included among Renal Cell Carcinomas of Children and Adolescents

Pedram Argani*, Cristina R. Antonescu{ddagger}{ddagger}, Peter B. Illei{ddagger}{ddagger}, Man Yee Lui{ddagger}{ddagger}, Charles F. Timmons{dagger}, Robert Newbury{ddagger}, Victor E. Reuter{ddagger}{ddagger}, A. Julian Garvin§, Antonio R. Perez-Atayde,||, Jonathan A. Fletcher,||, J. Bruce Beckwith**, Julia A. Bridge{dagger}{dagger} and Marc Ladanyi{ddagger}{ddagger}

From the Department of Pathology,*
The Johns Hopkins Hospital, Baltimore, Maryland; the Department of Pathology,{dagger}
Children’s Medical Center, Dallas, Texas; the Department of Pathology,{ddagger}
Children’s Hospital San Diego, California; the Department of Pathology,§
Baptist Medical Center–Wake Forest University, Winston-Salem, North Carolina; the Department of Pathology,
Children’s Hospital and Brigham and Women’s Hospital, Boston, Massachusetts; the Department of Pathology,||
Harvard Medical School, Boston, Massachusetts; the Department of Pathology,**
Loma Linda University, Loma Linda, California; Departments of Pathology, Pediatrics, and Orthopaedic Surgery,{dagger}{dagger}
University of Nebraska Medical Center, Omaha, Nebraska; and the Department of Pathology{ddagger}{ddagger}
Memorial Sloan-Kettering Cancer Center, New York, New York

The unbalanced translocation, der(17)t(X;17)(p11.2;q25), is characteristic of alveolar soft part sarcoma (ASPS). We have recently shown that this translocation fuses the TFE3 transcription factor gene at Xp11.2 to ASPL, a novel gene at 17q25. We describe herein eight morphologically distinctive renal tumors occurring in young people that bear the identical ASPL-TFE3 fusion transcript as ASPS, with the distinction that the t(X;17) translocation is cytogenetically balanced in these renal tumors. A relationship between these renal tumors and ASPS was initially suggested by the cytogenetic finding of a balanced t(X;17)(p11.2;q25) in two of the cases, and the ASPL-TFE3 fusion transcripts were then confirmed by reverse transcriptase-polymerase chain reaction. The morphology of these eight ASPL-TFE3 fusion-positive renal tumors, although overlapping in some aspects that of classic ASPS, more closely resembles renal cell carcinoma (RCC), which was the a priori diagnosis in all cases. These tumors demonstrate nested and pseudopapillary patterns of growth, psammomatous calcifications, and epithelioid cells with abundant clear cytoplasm and well-defined cell borders. By immunohistochemistry, four tumors were negative for all epithelial markers tested, whereas four were focally positive for cytokeratin and two were reactive for epithelial membrane antigen (EMA) (one diffusely, one focally). Electron microscopy of six tumors demonstrated a combination of ASPS-like features (dense granules in four cases, rhomboid crystals in two cases) and epithelial features (cell junctions in six cases, microvilli and true glandular lumens in three cases). Overall, although seven of eight tumors demonstrated at least focal epithelial features by electron microscopy or immunohistochemistry, the degree and extent of epithelial differentiation was notably less than expected for typical RCC. We confirmed the balanced nature of the t(X;17) translocation by fluorescence in situ hybridization in all seven renal tumors thus analyzed, which contrasts sharply with the unbalanced nature of the translocation in ASPS. In summary, a subset of tumors previously considered to be RCC in young people are in fact genetically related to ASPS, although their distinctive morphological and genetic features justify their classification as a distinctive neoplastic entity. Finally, the finding of distinctive tumors being associated with balanced and unbalanced forms of the same translocation is to our knowledge, unprecedented.





This article has been cited by other articles:


Home page
INT J SURG PATHOLHome page
Ni Wayan Winarti, P. Argani, A. M. De Marzo, J. Hicks, and K. Mulyadi
Pediatric Renal Cell Carcinoma Associated With Xp11.2 Translocation/TFE3 Gene Fusion
International Journal of Surgical Pathology, January 1, 2008; 16(1): 66 - 72.
[Abstract] [PDF]


Home page
Clin. Cancer Res.Home page
A. J.F. Lazar, P. Das, D. Tuvin, B. Korchin, Q. Zhu, Z. Jin, C. L. Warneke, P. S. Zhang, V. Hernandez, D. Lopez-Terrada, et al.
Angiogenesis-Promoting Gene Patterns in Alveolar Soft Part Sarcoma
Clin. Cancer Res., December 15, 2007; 13(24): 7314 - 7321.
[Abstract] [Full Text] [PDF]


Home page
INT J SURG PATHOLHome page
S. Suzigan, R. Drut, P. Faria, P. Argani, A. M. De Marzo, R. N. Barbosa, E. R. Mello Denadai, J. Martins-Filho, R. C. Martucci, and T. Bauab Jr.
Xp11 Translocation Carcinoma of the Kidney Presenting With Multilocular Cystic Renal Cell Carcinoma-Like Features
International Journal of Surgical Pathology, April 1, 2007; 15(2): 199 - 203.
[Abstract] [PDF]


Home page
Cancer Res.Home page
M. Tsuda, I. J. Davis, P. Argani, N. Shukla, G. G. McGill, M. Nagai, T. Saito, M. Lae, D. E. Fisher, and M. Ladanyi
TFE3 Fusions Activate MET Signaling by Transcriptional Up-regulation, Defining Another Class of Tumors as Candidates for Therapeutic MET Inhibition
Cancer Res., February 1, 2007; 67(3): 919 - 929.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
A L Folpe and A T Deyrup
Alveolar soft-part sarcoma: a review and update.
J. Clin. Pathol., November 1, 2006; 59(11): 1127 - 1132.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. S. Sunde, H. Donninger, K. Wu, M. E. Johnson, R. G. Pestell, G. S. Rose, S. C. Mok, J. Brady, T. Bonome, and M. J. Birrer
Expression Profiling Identifies Altered Expression of Genes That Contribute to the Inhibition of Transforming Growth Factor-{beta} Signaling in Ovarian Cancer.
Cancer Res., September 1, 2006; 66(17): 8404 - 8412.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. M. B. Nijman, E. M. Hijmans, S. E. Messaoudi, M. M. W. van Dongen, C. Sardet, and R. Bernards
A Functional Genetic Screen Identifies TFE3 as a Gene That Confers Resistance to the Anti-proliferative Effects of the Retinoblastoma Protein and Transforming Growth Factor-beta
J. Biol. Chem., August 4, 2006; 281(31): 21582 - 21587.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
P. Argani, M. Lae, E. T. Ballard, M. Amin, C. Manivel, B. Hutchinson, V. E. Reuter, and M. Ladanyi
Translocation Carcinomas of the Kidney After Chemotherapy in Childhood
J. Clin. Oncol., April 1, 2006; 24(10): 1529 - 1534.
[Abstract] [Full Text] [PDF]


Home page
INT J SURG PATHOLHome page
J. Rosai
Clear Cell Sarcoma and Osteoclast-Rich Clear Cell Sarcoma-Like Tumor of the Gastrointestinal Tract: One Tumor Type or Two? Melanoma or Sarcoma?
International Journal of Surgical Pathology, October 1, 2005; 13(4): 309 - 311.
[PDF]


Home page
Nucleic Acids ResHome page
R. P. Kuiper, M. Schepens, J. Thijssen, E. F. P. M. Schoenmakers, and A. G. van Kessel
Regulation of the MiTF/TFE bHLH-LZ transcription factors through restricted spatial expression and alternative splicing of functional domains
Nucleic Acids Res., April 26, 2004; 32(8): 2315 - 2322.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
J. Holzbeierlein, P. Lal, E. LaTulippe, A. Smith, J. Satagopan, L. Zhang, C. Ryan, S. Smith, H. Scher, P. Scardino, et al.
Gene Expression Analysis of Human Prostate Carcinoma during Hormonal Therapy Identifies Androgen-Responsive Genes and Mechanisms of Therapy Resistance
Am. J. Pathol., January 1, 2004; 164(1): 217 - 227.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Alaminos, J. Mora, N.-K. V. Cheung, A. Smith, J. Qin, L. Chen, and W. L. Gerald
Genome-wide Analysis of Gene Expression Associated with MYCN in Human Neuroblastoma
Cancer Res., August 1, 2003; 63(15): 4538 - 4546.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
R. P. Kuiper, M. Schepens, J. Thijssen, M. van Asseldonk, E. van den Berg, J. Bridge, E. Schuuring, E. F.P.M. Schoenmakers, and A. G. van Kessel
Upregulation of the transcription factor TFEB in t(6;11)(p21;q13)-positive renal cell carcinomas due to promoter substitution
Hum. Mol. Genet., July 15, 2003; 12(14): 1661 - 1669.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
I. J. Davis, B.-L. Hsi, J. D. Arroyo, S. O. Vargas, Y. A. Yeh, G. Motyckova, P. Valencia, A. R. Perez-Atayde, P. Argani, M. Ladanyi, et al.
Cloning of an Alpha-TFEB fusion in renal tumors harboring the t(6;11)(p21;q13) chromosome translocation
PNAS, May 13, 2003; 100(10): 6051 - 6056.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
M. E. Sanders, R. Mick, J. E. Tomaszewski, and F. G. Barr
Unique Patterns of Allelic Imbalance Distinguish Type 1 from Type 2 Sporadic Papillary Renal Cell Carcinoma
Am. J. Pathol., September 1, 2002; 161(3): 997 - 1005.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the American Society for Investigative Pathology.